A distal Foxp3 enhancer enables interleukin-2 dependent thymic Treg cell lineage commitment for robust immune tolerance

Stanislav Dikiy,Jun Li,Lu Bai,Menglin Jiang,Laura Janke,Xinying Zong,Xiaolei Hao,Beatrice Hoyos,Zhong-Min Wang,Beisi Xu,Yiping Fan,Alexander Y Rudensky,Yongqiang Feng,Alexander Y. Rudensky
DOI: https://doi.org/10.1016/j.immuni.2021.03.020
IF: 32.4
2021-05-01
Immunity
Abstract:Activation of the STAT5 transcription factor downstream of the Interleukin-2 receptor (IL-2R) induces expression of <em>Foxp3</em>, a critical step in the differentiation of regulatory T (Treg) cells. Due to the pleiotropic effects of IL-2R signaling, it is unclear how STAT5 acts directly on the <em>Foxp3</em> locus to promote its expression. Here, we report that IL-2 – STAT5 signaling converged on an enhancer (CNS0) during <em>Foxp3</em> induction. CNS0 facilitated the IL-2 dependent CD25<sup>+</sup>Foxp3<sup>–</sup> precursor to Treg cell transition in the thymus. Its deficiency resulted in impaired Treg cell generation in neonates, which was partially mitigated with age. While the thymic Treg cell paucity caused by CNS0 deficiency did not result in autoimmunity on its own, it exacerbated autoimmune manifestations caused by disruption of the <em>Aire</em> gene. Thus, CNS0 enhancer activity ensures robust Treg cell differentiation early in postnatal life and cooperatively with other tolerance mechanisms minimizes autoimmunity.
immunology
What problem does this paper attempt to address?